Ando T, Motokawa I, Sakurai K, Ohmura Y, Fujii T, Matsunaga K, Yoshikumi C, Nomoto K
Biomedical Research Laboratories, Kureha Chemical Industry Co., Ltd, Tokyo, Japan.
Cancer Chemother Pharmacol. 1987;20(3):198-202. doi: 10.1007/BF00570484.
C3H/He mice were inoculated with Pseudomonas aeruginosa by various routes 1 day after X5563 transplantation or 4 days after cyclophosphamide (CY) administration. Administration of PSK (Krestin) i.p. or p.o. to the tumor-bearing mice or CY-treated tumor-bearing mice resulted in an increase in survival rates. Viable P. aeruginosa were inoculated i.v. on day 0 into mice inoculated with tumor cells on day -12 and vaccinated with killed P. aeruginosa on day -10, or into mice inoculated with tumor cells on day -15, treated with CY on day -14 and vaccinated on day -10. Resistance to infection, which is enhanced by vaccination, was depressed by tumor burden or treatment with CY, but such depression was prevented by PSK administration.